Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Dec'18
Net Sales
90.05
70.19
37.05
22.24
18.37
11.79
28.40
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
90.05
70.19
37.05
22.24
18.37
11.79
28.40
Raw Material Cost
39.81
30.76
22.70
14.71
13.75
15.18
14.59
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
59.77
41.83
30.52
24.36
23.33
21.73
29.07
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
7.95
5.77
2.74
1.98
1.54
0.51
0.08
Selling and Distribution Expenses
63.78
59.93
47.53
30.22
28.61
30.87
43.04
Other Expenses
-5.72
-4.12
-2.80
-2.10
-2.18
-1.97
-2.61
Total Expenditure (Excl Depreciation)
114.15
97.06
75.47
50.24
45.43
48.61
60.73
Operating Profit (PBDIT) excl Other Income
-24.1
-26.9
-38.4
-28
-27.1
-36.800000000000004
-32.3
Other Income
1.15
0.09
0.17
1.00
0.21
-0.05
-0.08
Operating Profit (PBDIT)
-14.91
-19.92
-33.34
-23.97
-23.51
-33.45
-29.47
Interest
7.95
5.77
2.74
1.98
1.54
0.51
0.08
Exceptional Items
-6.79
-10.55
-3.06
-0.02
-0.27
-6.29
0.00
Gross Profit (PBDT)
50.24
39.44
14.35
7.53
4.62
-3.39
13.81
Depreciation
8.04
6.86
4.91
3.04
3.33
3.42
2.94
Profit Before Tax
-37.69
-43.10
-44.04
-29.00
-28.66
-43.68
-32.49
Tax
0.38
0.00
0.00
0.00
0.00
-0.58
-0.04
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
-38.07
-43.10
-44.04
-29.00
-28.66
-43.10
-32.45
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
-38.07
-43.10
-44.04
-29.00
-28.66
-43.10
-32.45
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
-38.07
-43.10
-44.04
-29.00
-28.66
-43.10
-32.45
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
14.84
7.21
9.32
46.90
5.85
19.72
52.12
Earnings per share (EPS)
-1.16
-1.66
-2.78
-2.38
-3.44
-6.89
-5.63
Diluted Earnings per share
-1.16
-1.66
-2.78
-2.38
-3.44
-6.89
-5.63
Operating Profit Margin (Excl OI)
-26.76%
-38.27%
-103.67%
-125.91%
-147.27%
-312.47%
-113.86%
Gross Profit Margin
-32.92%
-51.63%
-105.62%
-116.76%
-137.87%
-341.58%
-104.07%
PAT Margin
-42.28%
-61.4%
-118.86%
-130.41%
-156.01%
-365.72%
-114.27%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Dec 2024 is 28.21% vs 89.22% in Dec 2023
Consolidate Net Profit
YoY Growth in year ended Dec 2024 is 11.60% vs 2.05% in Dec 2023
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Dec 2024 is 19.50% vs 40.30% in Dec 2023
Interest
YoY Growth in year ended Dec 2024 is 37.93% vs 114.81% in Dec 2023
Operating Profit Margin (Excl OI)
YoY Growth in year ended Dec 2024 has improved from Dec 2023
Compare Annual Results Of MDxHealth SA With
Figures in Million
Consolidate Annual Results
Change(USD)
Change(%)
Net Sales
90.05
0.71
89.34
12,583.10%
Other Operating Income
0.00
0.00
0.00
Total Operating income
90.05
0.71
89.34
12,583.10%
Raw Material Cost
39.81
4.87
34.94
717.45%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
59.77
0.00
59.77
Power Cost
0
0
0.00
Manufacturing Expenses
7.95
4.29
3.66
85.31%
Selling and Distribution Expenses
63.78
25.34
38.44
151.70%
Other Expenses
-5.72
-0.43
-5.29
-1,230.23%
Total Expenditure (Excl Depreciation)
114.15
30.20
83.95
277.98%
Operating Profit (PBDIT) excl Other Income
-24.10
-29.49
5.39
18.28%
Other Income
1.15
1.68
-0.53
-31.55%
Operating Profit (PBDIT)
-14.91
-27.15
12.24
45.08%
Interest
7.95
4.29
3.66
85.31%
Exceptional Items
-6.79
0.00
-6.79
Gross Profit (PBDT)
50.24
-4.15
54.39
1,310.60%
Depreciation
8.04
0.66
7.38
1,118.18%
Profit Before Tax
-37.69
-32.10
-5.59
-17.41%
Tax
0.38
0.47
-0.09
-19.15%
Provisions and contingencies
0
0
0.00
Profit After Tax
-38.07
-32.56
-5.51
-16.92%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
-38.07
-32.56
-5.51
-16.92%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
-38.07
-32.56
-5.51
-16.92%
Equity Capital
0
0
0.00
Face Value
0.00
0.00
0.00
Reserves
14.84
-19.47
34.31
176.22%
Earnings per share (EPS)
-1.16
-1.22
0.06
4.92%
Diluted Earnings per share
-1.16
-1.22
0.06
4.92%
Operating Profit Margin (Excl OI)
-26.76%
-4,142.13%
0.00
4,115.37%
Gross Profit Margin
-32.92%
-4,415.31%
0.00
4,382.39%
PAT Margin
-42.28%
-4,573.60%
0.00
4,531.32%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 9.00 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is 28.21% vs 89.22% in Dec 2023
Annual - Consolidate Net Profit
Consolidate Net Profit -3.81 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is 11.60% vs 2.05% in Dec 2023
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) -1.61 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is 19.50% vs 40.30% in Dec 2023
Annual - Interest
Interest 0.80 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is 37.93% vs 114.81% in Dec 2023
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) -26.76%
in Dec 2024Figures in %
YoY Growth in year ended Dec 2024 has improved from Dec 2023






